Correction: Patient eligibility for trials with imaging response assessment at the time of molecular...
Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Alternative Titles
Full title
Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a22b6c35648c4250bc7b8c9caf5f9505
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a22b6c35648c4250bc7b8c9caf5f9505
Other Identifiers
ISSN
1470-7330,1740-5025
E-ISSN
1470-7330
DOI
10.1186/s40644-024-00724-5